REFERENCES

 For parents, caregivers, health care providers, and teachers, concerns and questions often arise regarding the care and well-being of individuals with Pitt-Hopkins syndrome. 

1

1 Pitt D, Hopkins I. A syndrome of mental retardation, wide mouth and intermittent overbreathing. Austr Paediatr. 1978;14:182-184.

2

2. Marangi G, Ricciardi S, Orteschi D, Lattante S, Murdolo M, Dallapiccola B, Biscione C, Lecce R, Chiurazzi P, Romano C, Greco D, Pettinato R, Sorge G, Pantaleoni C, Alfei E, Toldo I, Magnani C, Bonanni P, Martinez F, Serra G, Battaglia D, Lettori D, Vasco G, Baroncini A, Daolio C, Zollino M. The Pitt-Hopkins syndrome: report
of 16 new patients and clinical diagnostic criteria. Am J Med Genet 2011;155A:1536–1545, 155.

3

3. Whalen S, Heron D, Gaillon T, et al. Novel comprehensive diagnostic strategy in Pitt-Hopkins syndrome: clinical score and further delineation of the TCF4 mutational spectrum. Hum Mutat. 2012;33:64-72.

4

4. De Winter CF, Baas M, Bijlsma EK, van Heukelingen J, Routledge S, Hennekam RC. Phenotype and natural history in 101 individuals with Pitt-Hopkins syndrome through an Internet questionnaire system. Orphanet J Rare Dis. 2016;11:37.

5

5. Sepp M, Kannike K, Eesmaa A, Urb M, Timmusk T. Functional diversity of human basic helix-loop-helix transcription factor TCF4 isoforms generated by alternative 50 exon usage and splicing. PLoS One. 2011;6:
e22138.

6

6. Stefansson H, Ophoff RA, Steinberg S, et al. Common variants conferring risk of schizophrenia. Nature. 2009;460:744-747.

7

7. Baratz KH, Tosakulwong N, Ryu E, et al. E2-2 protein and Fuchs's corneal dystrophy. N Engl J Med. 2010;363:1016-1024.

8

8. Ellinghaus D, Folseraas T, Holm K, et al. Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4. Hepatology. 2013;58:1074-1083.

9

9. Corneliussen B, Thornell A, Hallberg B, Grundstrom T. Helix-loop-helix transcriptional activators bind to a sequence in glucocorticoid response elements of retrovirus enhancers. J Virol. 1991;65:6084-6093.

10

10. Zhuang Y, Cheng P, Weintraub H. B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB. Mol Cell Biol. 1996;16:2898-2905.

11

11: Bergqvist I, Eriksson M, Saarikettu J, et al. The basic helix-loop-helix transcription factor E2-2 is involved in T lymphocyte development. Eur J Immunol. 2000;30:2857-2863.

12

12. Cano A, Portillo F. An emerging role for class I bHLH E2-2 proteins in EMT regulation and tumor progression. Cell Adh Migr. 2010;4:56-60.

13

13. Bertrand N, Castro DS, Guillemot F. Proneural genes and the specification of neural cell types. Nat Rev Neurosci. 2002;3:517-530.

14

14. Zweier C, Peippo MM, Hoyer J, et al. Haploinsufficiency of TCF4 causes syndromal mental retardation with intermittent hyperventilation (Pitt-Hopkins syndrome). Am J Hum Genet. 2007;80:994-1001.

15

15. de Pontual L, Mathieu Y, Golzio C, et al. Mutational, functional, and expression studies of the TCF4 gene in Pitt-Hopkins syndrome. Hum Mutat. 2009;30:669-676.

16

16. Amiel J, Rio M, de Pontual L, et al. Mutations in TCF4, encoding a class I basic helix-loop-helix transcription factor, are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with autonomic dysfunction. Am J Hum Genet. 2007;80:988-993.

17

17. Andrieux J, Lepretre F, Cuisset JM, et al. Deletion 18q21.2q21.32 involving TCF4 in a boy diagnosed by CGH-array. Eur J Med Genet. 2008;51:172-177.

18

18. Giurgea I, Missirian C, Cacciagli P, et al. TCF4 deletions in Pitt-Hopkins syndrome. Hum Mutat. 2008;29:E242-E251.

19

19. Rosenfeld JA, Leppig K, Ballif BC, et al. Genotype-phenotype analysis of TCF4 mutations causing Pitt-Hopkins syndrome shows increased seizure activity with missense mutations. Genet Med. 2009;11: 797-805.

20

20. Kato Z, Morimoto W, Kimura T, Matsushima A, Kondo N. Interstitial deletion of 18q: comparative genomic hybridization array analysis of
46, XX,del(18)(q21.2.q21.33). Birth Defects Res A Clin Mol Teratol. 2010;88:132-135.

21

21. Stavropoulos DJ, MacGregor DL, Yoon G. Mosaic microdeletion 18q21 as a cause of mental retardation. Eur J Med Genet. 2010;53: 396-399.

22

22. Goodspeed K, Newsom C, Morris MA, Powell C, Evans P, Golla S. Pitt-Hopkins syndrome: A review of current literature, clinical approach, and 23-patient case series. J Child Neurol. 2018;33:233-244.

23

23. Hasi M, Soileau B, Sebold C, et al. The role of the TCF4 gene in the phenotype of individuals with 18q segmental deletions. Hum Genet. 2011;130:777-787.

24

24. Rossi M, Labalme A, Cordier MP, et al. Mosaic 18q21.2 deletions including the TCF4 gene: a clinical report. Am J Med Genet. 2012; 158A:3174-3181.

25

25. Takenouchi T, Yagihashi T, Tsuchiya H, et al. Tissue-limited ring chromosome 18 mosaicism as a cause of Pitt-Hopkins syndrome. Am J Med Genet. 2012;158A:2621-2623.

26

26. Kalscheuer VM, Feenstra I, Van Ravenswaaij-Arts CM, et al. Disruption of the TCF4 gene in a girl with mental retardation but without the classical Pitt-Hopkins syndrome. Am J Med Genet. 2008;146A: 2053-2059.

27

27. Talkowski ME, Rosenfeld JA, Blumenthal I, et al. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell. 2012;149:525-537. 

28

28. Schluth-Bolard C, Labalme A, Cordier MP, et al. Breakpoint mapping by next generation sequencing reveals causative gene disruption in patients carrying apparently balanced chromosome rearrangements with intellectual deficiency and/or congenital malformations. J Med Genet. 2013;50:144-150.

29

29. Maduro V, Pusey BN, Cherukuri PF, et al. Complex translocation disrupting TCF4 and altering TCF4 isoform expression segregates as mild autosomal dominant intellectual disability. Orphanet J Rare Dis. 2016; 11:62.

30

30. Zweier C, Sticht H, Bijlsma EK, et al. Further delineation of Pitt-Hopkins syndrome: phenotypic and genotypic description of 16 novel patients. J Med Genet. 008;45:738-744.

31

31. Brockschmidt A, Todt U, Ryu S, et al. Severe mental retardation with breathing abnormalities (Pitt–Hopkins syndrome) is caused by haploinsufficiency of the neuronal bHLH transcription factor TCF4. Hum Mol Genet. 2007;16:1488-1494.

32

32. Lehalle D, Williams C, Siu VM, Clayton-Smith J. Fetal pads as a clue to the diagnosis of Pitt-Hopkins syndrome. Am J Med Genet. 2011;155A: 1685-1689.

33

33. Bedeschi MF, Marangi G, Calvello MR. Impairment of different protein domains causes variable clinical presentation within Pitt-Hopkins syndrome and suggests intragenic molecular syndromology of TCF4. Eur J Med Genet. 2017;60:565-571.

34

34. Hamdan FF, Daoud H, Patry L, et al. Parent-child exome sequencing identifies a de novo truncating mutation in TCF4 in non-syndromic intellectual disability. Clin Genet. 2013;83:198-200.

35

35. Redin C, Gérard B, Lauer J, et al. Efficient strategy for the molecular diagnosis of intellectual disability using targeted high-throughput sequencing. J Med Genet. 2014;51:724-736.

36

36. Kharbanda M, Kannike K, Lampe A, Berg J, Timmusk T, Sepp M. Partial deletion of TCF4 in three generation family with non-syndromic intellectual disability, without features of Pitt-Hopkins syndrome. Eur J Med Genet. 2016;59:310-314.

37

37. Mary L, Piton A, Schaefer E, et al. Disease-causing variants in TCF4 are a frequent cause of intellectual disability: lessons from large-scale sequencing approaches in diagnosis. Eur J Hun Genet. 2018;26:996-1006.

38

38. Tan CA, Topper S, Del Gaudio D, et al. Characterization of patients referred for non-specific intellectual disability testing: the importance
of autosomal genes for diagnosis. Clin Genet. 2016;89:478-483.

39

39. Zweier C, de Jong EK, Zweier M, et al. CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. Am J Hum Genet. 2009;85:655-666.

40

40. Harrison V, Connell L, Hayesmoore J, McParland J, Pike MG, Blair E. Compound heterozygous deletion of NRXN1 causing severe developmental delay with early onset epilepsy in two sisters. Am J Med Genet 2011;155A:2826–2831, 155.

41

41. Smogavec M, Cleall A, Hoyer J, et al. Eight further individuals with intellectual disability and epilepsy carrying bi-allelic CNTNAP2 aberrations allow delineation of the mutational and phenotypic spectrum. J Med Genet. 2016;53:820-827.

42

42. Kousoulidou L, Tanteles G, Moutafi M, Sismani C, Patsalis PC, Anastasiadou V. 263.4 kb deletion within the TCF4 gene consistent with Pitt-Hopkins syndrome, inherited from a mosaic parent with normal phenotype. Eur J Med Genet. 2013;56:314-318.

43

43. Steinbusch CV, van Roozendaal KE, Tserpelis D, et al. Somatic mosaicism in a mother of two children with Pitt-Hopkins syndrome. Clin Genet. 2013;83:73-77.

44

44. Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86:749-764.

45

45. Grubisic V, Kennedy AJ, Sweatt JD, Parpura V. Pitt-Hopkins mouse model has altered particular gastrointestinal transits in vivo. Autism Res. 2015;8:629-633.

46

46. Van Balkom ID, Quartel S, Hennekam RC. Mental retardation, "coarse" face, and hyperbreathing: confirmation of the Pitt-Hopkins syndrome. Am J Med Genet. 1998;75:273-276.

47

47. Marangi G, Zollino M. Pitt-Hopkins syndrome and differential diagnosis: a molecular and clinical challenge. J Pediatr Genet. 2015;4: 168-176.

48

48. North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Evaluation and treatment of constipation in children: summary of updated recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2006;43:405-407.

49

49. Buonavolontà R, Boccia G, Turco R, Quitadamo P, Russo D, Staiano A. Pediatric functional gastrointestinal disorders: a questionnaire on pediatric gastrointestinal symptoms based on Rome III criteria. Minerva Pediatr. 2009;61:67-91.

50

50. Vandenplas Y, Rudolph CD, Di Lorenzo C, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr. 2009;49:498-547.

51

51. Romano C, van Wynckel M, Hulst J, et al. European Society for Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for the evaluation and treatment of gastrointestinal and nutritional complications in children with neurological impairment. J Pediatr Gastroenterol Nutr. 2017;65:242-264.

52

52. Marangi G, Ricciardi S, Orteschi D, et al. Proposal of a clinical score for the molecular test for Pitt-Hopkins syndrome. Am J Med Genet. 2012;158A:1604-1611.

53

53. Verhulst SL, De Dooy J, Ramet J, et al. Acetazolamide for severe apnea in Pitt-Hopkins syndrome. Am J Med Genet. 2012;158A: 932-934.

54

54. Taddeuchi G, Bonuccelli A, Mantellassi I, Orsini A, Tarantino E. Pitt-Hopkins syndrome: Report of a case with a TCF4 gene mutation. Ital J Pediatr. 2010;36:12-17.

55

55. Motojima T, Fujii K, Ohashi H, Arakawa H. Catathrenia in Pitt-Hopkins syndrome associated with 18q interstitial deletion. Pediatr Int. 2018; 60:479-481.

56

56. Gaffney C, McNally P. Successful use of acetazolamide for central apnea in a child with Pitt-Hopkins syndrome. Am J Med Genet. 2015; 167A:1423.

57

57. Swenson ER, Leatham KL, Roach RC, Schoene RB, Mills WJ Jr, Hackett PH. Renal carbonic anhydrase inhibition reduces high altitude sleep periodic breathing. Respir Physiol. 1991;86:333-343.

58

58. Swenson ER, Hughes JM. Effects of acute and chronic acetazolamide on resting ventilation and ventilatory responses in men. J Appl Physiol. 1993;74:230-237.

59

59. Bickler PE, Litt L, Banville DL, Severinghaus JW. Effects of acetazolamide on cerebral acid–base balance. J Appl Physiol. 1988;65: 422-427.

60

60. Bonnet MH, Dexter JR, Arand DL. The effect of triazolam on arousal and respiration in central sleep apnea patients. Sleep. 1990;13:31-41.

61

61. Quadri S, Drake C, Hudgel DW. Improvement of idiopathic central sleep apnea with zolpidem. J Clin Sleep Med. 2009;5:122-129.

62

62. Aurora RN, Chowdhuri S, Ramar K, et al. The treatment of central sleep apnea syndromes in adults: practice parameters with an evidence-based literature review and meta-analyses. Sleep. 2012;35:17-40.

63

63. Abdala AP, Lioy DT, Garg SK, Knopp SJ, Paton JF, Bissonnette JM. Effect of Sarizotan, a 5-HT1a and D2-like receptor agonist, on respiration in three mouse models of Rett syndrome. Am J Respir Cell Mol Biol. 2014;50:1031-1039.

64

64. Takano K, Lyons M, Moyes C, Jones J, Schwartz CE. Two percent of patients suspected of having Angelman syndrome have TCF4 mutations. Clin Genet. 2010;78:282-288.

65

65. Xu Z, Chen Y, Yu J, et al. TCF4 Mediates the maintenance of neuropathic pain through Wnt/β-Catenin signaling following peripheral nerve injury in rats. J Mol Neurosci. 2015;56:397-408.

66

66. Malviya S, Voepel-Lewis T, Burke C, Merkel S, Tait AR. The revised FLACC observational pain tool: improved reliability and validity for pain assessment in children with cognitive impairment. Paediatr Anaesth. 2006;16:258-265.

67

67. Sweatt JD. Pitt–Hopkins syndrome: Intellectual disability due to Loss of TCF4-regulated gene transcription. Exp Mol Med. 2013;45:e21.

68

68. Kennedy AJ, Rahn EJ, Paulukaitis BS, et al. Tcf4 regulates synaptic plasticity, DNA methylation, and memory function. Cell Rep. 2016;16: 2666-2685.

69

69. Peippo MM, Simola KOJ, Valanne LK, et al. Pitt–Hopkins syndrome in two patients and further definition of the phenotype. Clin Dysmorphol. 2006;15:47-54.

70

70. Bouchard M, Mosca VS. Flatfoot deformity in children and adolescents: Surgical indications and management. J Am Acad Orthop Surg. 2014;22:623-632.

71

71. Bauer K, Mosca VS, Zionts LE. What's new in pediatric flatfoot? J Pediatr Orthop. 2016;36:865-869.

72

72. Avina Fierro JA, Avina DA. Pitt-Hopkins syndrome: mental retardation, psychomotor and developmental delays with facial dysmorphism. J Pediatr Genet. 2014;3:141-145.

73

73. Norwood KW Jr, Slayton RL. Council on children with disabilities - Section on oral health. Oral health care for children with developmental disabilities. Pediatrics. 2013;131:614-619.

74

74. See P, Dutertre CA, Chen J, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356(6342):eaag3009.

75

75. Cisse B, Caton ML, Lehner M, et al. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell. 2008;135:37-48.

76

76. Singh HA. Mental retardation, macrostomia and hyperpnoea syndrome. J Paediatr Child Health. 1993;29:156-157.

77

77. Soileau B, Gasi M, Sebold C, et al. Adults with chromosome 18 abnormalities. J Genet Couns. 2015;24:663-674.

78

78. Van Balkom IDC, Vuijk PJ, Franssens M, Hoek HW, Hennekam RCM. Development, cognition, and behaviour in Pitt–Hopkins syndrome. Develop Med Child Neurol. 2012;54:925-931.

79

79. Baas M, Huisman S, van Heukelingen J, Koekkoek G, Laan HW, Hennekam RC. Building treasures for rare disorders. Eur J Med Genet. 2015;58:11-13.

80

80. Ailey SH, Brown PJ, Ridge CM. Improving hospital care of patients with intellectual and developmental disabilities. Disabil Health J. 2017; 10:169-172.

81

81. Waldboth V, Patch C, Mahrer-Imhof R, Metcalfe A. Living a normal life in an extraordinary way: A systematic review investigating experiences of families of young people's transition into adulthood when affected by a genetic and chronic childhood condition. Int J Nurs Stud. 2016;62:44-59.

82

82. Quint EH. Menstrual and reproductive issues in adolescents with physical and developmental disabilities. Obstet Gynecol. 2014;124:367-375.

83

83. Tamberg L, Sepp M, Timmusk T, Palgi M. Introducing Pitt-Hopkins syndrome-associated mutations of TCF4 to Drosophila daughterless. Biol Open. 2015;4:1762-1771.

84

84. Sepp M, Pruunsild P, Timmusk T. Pitt-Hopkins syndrome-associated mutations in TCF4 lead to variable impairment of the transcription factor function ranging from hypomorphic to dominant-negative effects. Hum Mol Genet. 2012;21:2873-2888.

85

85. Rannals MD, Page SC, Campbell MN, Gallo RA, Mayfield B, Maher BJ. Neurodevelopmental models of Transcription Factor 4 deficiency converge on a common ion channel as a potential therapeutic target for Pitt Hopkins syndrome. Rare Diseases. 2016;5:e1220468.

86

86. Van Balkom H, Deckers S, Stoep J. Assessment of communicative competence in children with severe developmental disorders. In: Segers E, van den Broek P, eds. Developmental perspectives in written language and literacy. Amsterdam, the Netherlands: John Benjamins; 2017:413-439.

87

87. Hassiotis A, Robotham D, Canagasabey A, et al. Randomized, single-blind, controlled trial of a specialist behavior therapy team for challenging behavior in adults with intellectual disabilities. Am J Psychiatry. 2009;16(11):1278-1285.

88

88. Pillay J, Boylan K, Newton A, et al. Harms of antipsychotics in children and young adults: A systematic review update. Can J Psychiatry. 2018; 63:661-678.

 xwiki:WaihonaPartners.amcPTHS.WebHome